A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single‐blind randomized controlled trial
Transfusion2015Vol. 55(7), pp. 1644–1654
Citations Over TimeTop 10% of 2015 papers
Luca Weltert, Beatrice Rondinelli, Ricardo Bello, M Falco, Alessandro Bellisario, Daniele Maselli, Franco Turani, Ruggero De Paulis, Luca Pierelli
Abstract
In anemic patients (Hb<13 g/dL), a single high dose of HRE administered 2 days before cardiac surgery is effective in reducing the incidence of aRBCt without increasing adverse events.
Related Papers
- → Safety of Bojungikgi-tang Soft Extract after Single Oral Administration in Healthy Male Volunteers, Single Center Study(2021)2 cited
- → Urgent ERCP performed with single-use duodenoscope (SUD) in patients with moderate-to-severe cholangitis: Single-center prospective study(2023)2 cited
- → Initial experience with 50 laparoendoscopic single site surgeries using a homemade, single port device at a single center(2010)
- → ENDOSCOPIC ULTRASOUND USING A SINGLE TYPE 22 GA NEEDLE FOR PANCREATIC LESIONS WITHOUT ROSE: A SINGLE CENTER, SINGLE OPERATOR RETROSPECTIVE STUDY(2020)
- → Randomised, single centre, single blind feasibility study to determine the safety and effectiveness of interferential stimulation when compared to standard of care for the maintenance of bone density in pre-menopausal women receiving a Gonadotropin-Releasing Hormone (GnRH) agonist(2012)